Market Overview:
The global ophthalmology drugs and devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising geriatric population, and technological advancements in ophthalmic devices. The global ophthalmology drugs and devices market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into diagnostic and monitoring devices, surgical devices, vision care products (lenses & frames), and drugs. The diagnostic and monitoring devices segment is further sub-segmented into imaging equipment (ophthalmic ultrasound scanners & fundus cameras)and non-imaging equipment (tonometers & pachymeters). The surgical device segment is further sub-segmented into lasers & energy based systemsdevices), microsurgery instruments (forceps/scissors/curettes), phacoemulsification systems), intraocular lenses(IOLs)),and contact lenses). On the basis of application,the marketis dividedinto cataract surgery,, glaucoma surgery,, refractive error correction surgery,, vitreoretinal surgery,. Cataract surgeries are expected to account forthe largest shareof thismarketin 2018 owingtoits high prevalenceacross all regions studied in this research study .
Product Definition:
Ophthalmology Drugs & Devices are used to treat various eye conditions. They can include drugs to reduce inflammation, antibiotics to treat infection, or medications to correct vision problems.
Diagnostic and monitoring devices:
The global diagnostic and monitoring devices, it's usage and growth factor in Ophthalmology Drugs & Devices market size was valued at USD 5.5 billion in 2015. The increasing prevalence of ocular disorders such as glaucoma, cataract, diabetic retinopathy coupled with rising geriatric population base is expected to drive the demand over the forecast period. Furthermore, growing awareness levels amongst patients regarding early diagnosis of these diseases is anticipated to further boost the growth over next seven years.
Surgical devices:
Surgical devices are instruments that are used in ophthalmic surgeries. These surgical devices can be broadly segmented into viscosurgical, vitreoretinal and non-viscosural, non-vitreoretinal and others.
Application Insights:
Glaucoma held the largest share of the application segment in 2017. Glaucoma is a common ophthalmic disease that damages optic nerve and retinal ganglion cells, resulting in loss of vision. The disease is caused due to blockage of fluid drainage from eye which results in increased pressure inside the eye. As per WHO, glaucoma affects more than 60 million people across the world and it is expected to become one of the leading causes of blindness by 2030.
The cataract segment held a significant share as well as OPD revenue for lens-based devices contributed towards nearly 40% toward overall market revenue in 2017 owing to an increase in geriatric population globally which results into high demand for cataract surgery procedures performed daily worldwide. Cataract commonly occurs at older age groups (>55 years) but becomes rare before 10th decade (35 years).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high adoption rate for advanced devices and drugs, availability of reimbursement coverage, and increasing R&D activities by companies. In addition, rise in prevalence of ophthalmic disorders is expected to fuel growth during the forecast period. For instance, according to data published by National Eye Institute (NIH), around 29 million people suffer from vision loss due to age-related macular degeneration (AMD) in U.S., which is anticipated to increase over next few years.
Asia Pacific region is expected witness lucrative growth during the forecast period owing its rapidly growing economy coupled with rising disposable income leading towards improved healthcare facilities & infrastructure along with increased awareness about various treatment options available for eye diseases such as cataract surgery or refractive surgery among patients suffering from these conditions are some factors responsible for regional growth.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The global ophthalmology drugs & devices market is expected to grow at a CAGR of over 7% during the forecast period owing to the increasing prevalence of eye diseases and disorders. According to the World Health Organization (WHO), approximately 285 million people are visually impaired worldwide, out of which 39 million are blind and 246 million have low vision. This number is expected to increase due to the growing aging population and rising incidence of chronic eye diseases such as glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, etc.
- Rising demand for technologically advanced products: The ophthalmology drugs & devices market is witnessing a shift towards technologically advanced products with features such as better efficacy, safety, and convenience. For instance, in 2017, Alcon Laboratories Inc., acquired CooperVision Inc., a leading manufacturer of soft contact lenses with innovative technologies such as Aquaform Comfort Science™and Biofinity® lens materials. This acquisition will help Alcon strengthen its product portfolio in the contact lens segment while providing consumers with better quality products.
- Growing awareness about eye health: There has been an increasing awareness among people about the importance of good eye health across all age groups in recent years. This has led to an increase in demand for ophthalmic treatments and procedures across all regions globally. In addition, governments are also investing heavily in initiatives aimed at raising awareness about preventive measures that can be
Scope Of The Report
Report Attributes
Report Details
Report Title
Ophthalmology Drugs & Devices Market Research Report
By Type
Diagnostic and monitoring devices, Surgical devices, Vision care, Drugs
By Application
Cataract, Glaucoma, Refractive error, Vitreoretinal
By Companies
Abbott, Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Ellex  , Essilor  , Hoya, Iridex, Johnson & Johnson , Merck & Co. , Nidek Co. , Santen Pharmaceutical  , Novartis, Pfizer    , Roche Holding , Staar Surgical, Topcon, Ziemer Ophthalmic Systems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Ophthalmology Drugs & Devices Market Report Segments:
The global Ophthalmology Drugs & Devices market is segmented on the basis of:
Types
Diagnostic and monitoring devices, Surgical devices, Vision care, Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cataract, Glaucoma, Refractive error, Vitreoretinal
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Alcon
- Allergan
- Bausch & Lomb
- Carl Zeiss Meditec
- Ellex Â
- Essilor Â
- Hoya
- Iridex
- Johnson & JohnsonÂ
- Merck & Co.Â
- Nidek Co.Â
- Santen Pharmaceutical Â
- Novartis
- Pfizer   Â
- Roche HoldingÂ
- Staar Surgical
- Topcon
- Ziemer Ophthalmic Systems
Highlights of The Ophthalmology Drugs & Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic and monitoring devices
- Surgical devices
- Vision care
- Drugs
- By Application:
- Cataract
- Glaucoma
- Refractive error
- Vitreoretinal
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ophthalmology Drugs & Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ophthalmology drugs and devices are medications and devices used in the eye. These include treatments for conditions such as glaucoma, macular degeneration, cataracts, and diabetic retinopathy.
Some of the major companies in the ophthalmology drugs & devices market are Abbott, Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Ellex‚Â ‚Â , Essilor‚Â ‚Â , Hoya, Iridex, Johnson & Johnson‚Â , Merck & Co.‚Â , Nidek Co.‚Â , Santen Pharmaceutical‚Â ‚Â , Novartis, Pfizer‚Â ‚Â ‚Â ‚Â , Roche Holding‚Â , Staar Surgical, Topcon, Ziemer Ophthalmic Systems.
The ophthalmology drugs & devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ophthalmology Drugs & Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ophthalmology Drugs & Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ophthalmology Drugs & Devices Market - Supply Chain
4.5. Global Ophthalmology Drugs & Devices Market Forecast
4.5.1. Ophthalmology Drugs & Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ophthalmology Drugs & Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ophthalmology Drugs & Devices Market Absolute $ Opportunity
5. Global Ophthalmology Drugs & Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ophthalmology Drugs & Devices Market Size and Volume Forecast by Type
5.3.1. Diagnostic and monitoring devices
5.3.2. Surgical devices
5.3.3. Vision care
5.3.4. Drugs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ophthalmology Drugs & Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ophthalmology Drugs & Devices Market Size and Volume Forecast by Application
6.3.1. Cataract
6.3.2. Glaucoma
6.3.3. Refractive error
6.3.4. Vitreoretinal
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ophthalmology Drugs & Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ophthalmology Drugs & Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ophthalmology Drugs & Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ophthalmology Drugs & Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ophthalmology Drugs & Devices Demand Share Forecast, 2019-2029
9. North America Ophthalmology Drugs & Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ophthalmology Drugs & Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ophthalmology Drugs & Devices Market Size and Volume Forecast by Application
9.4.1. Cataract
9.4.2. Glaucoma
9.4.3. Refractive error
9.4.4. Vitreoretinal
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ophthalmology Drugs & Devices Market Size and Volume Forecast by Type
9.7.1. Diagnostic and monitoring devices
9.7.2. Surgical devices
9.7.3. Vision care
9.7.4. Drugs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ophthalmology Drugs & Devices Demand Share Forecast, 2019-2029
10. Latin America Ophthalmology Drugs & Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ophthalmology Drugs & Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ophthalmology Drugs & Devices Market Size and Volume Forecast by Application
10.4.1. Cataract
10.4.2. Glaucoma
10.4.3. Refractive error
10.4.4. Vitreoretinal
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ophthalmology Drugs & Devices Market Size and Volume Forecast by Type
10.7.1. Diagnostic and monitoring devices
10.7.2. Surgical devices
10.7.3. Vision care
10.7.4. Drugs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ophthalmology Drugs & Devices Demand Share Forecast, 2019-2029
11. Europe Ophthalmology Drugs & Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ophthalmology Drugs & Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ophthalmology Drugs & Devices Market Size and Volume Forecast by Application
11.4.1. Cataract
11.4.2. Glaucoma
11.4.3. Refractive error
11.4.4. Vitreoretinal
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ophthalmology Drugs & Devices Market Size and Volume Forecast by Type
11.7.1. Diagnostic and monitoring devices
11.7.2. Surgical devices
11.7.3. Vision care
11.7.4. Drugs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ophthalmology Drugs & Devices Demand Share, 2019-2029
12. Asia Pacific Ophthalmology Drugs & Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ophthalmology Drugs & Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ophthalmology Drugs & Devices Market Size and Volume Forecast by Application
12.4.1. Cataract
12.4.2. Glaucoma
12.4.3. Refractive error
12.4.4. Vitreoretinal
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ophthalmology Drugs & Devices Market Size and Volume Forecast by Type
12.7.1. Diagnostic and monitoring devices
12.7.2. Surgical devices
12.7.3. Vision care
12.7.4. Drugs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ophthalmology Drugs & Devices Demand Share, 2019-2029
13. Middle East & Africa Ophthalmology Drugs & Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ophthalmology Drugs & Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ophthalmology Drugs & Devices Market Size and Volume Forecast by Application
13.4.1. Cataract
13.4.2. Glaucoma
13.4.3. Refractive error
13.4.4. Vitreoretinal
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ophthalmology Drugs & Devices Market Size and Volume Forecast by Type
13.7.1. Diagnostic and monitoring devices
13.7.2. Surgical devices
13.7.3. Vision care
13.7.4. Drugs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ophthalmology Drugs & Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Ophthalmology Drugs & Devices Market: Market Share Analysis
14.2. Ophthalmology Drugs & Devices Distributors and Customers
14.3. Ophthalmology Drugs & Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alcon
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Allergan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bausch & Lomb
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Carl Zeiss Meditec
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ellex
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Essilor
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hoya
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Iridex
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Johnson & Johnson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Merck & Co.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Nidek Co.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Santen Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Novartis
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Pfizer
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Roche Holding
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Staar Surgical
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Topcon
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Ziemer Ophthalmic Systems
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
